-
Medicare soon will start something it hasn't done in its 58-year history: negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
-
Supporters say the proposed rules would balance the goals of increasing access to health care and helping prevent medication misuse. Opponents say the rules would make it difficult for some patients — especially those in rural areas — to get care.
-
The judge issued an order granting the FDA's request for a stay and noting that a trial is scheduled in November.
-
Sen. Bernie Sanders’ broad statement on U.S. drug prices doesn’t paint the full picture. Studies we examined generally found that U.S. prices were 2 to 4 times those in other countries, not 10.
-
The House Appropriations Committee on Friday approved a bill that would make a series of changes to regulate PBMs. The Senate unanimously passed its version on Wednesday.
-
The funds will help to implement strategies and expand programs for treatment, education and support in Florida as well as establish the DCF Office of Opioid Recovery.
-
Amazon will launch RxPass, a subscription service for customers who have Prime memberships. People will pay $5 a month to fill as many prescriptions as they need from a list of about 50 generic medications.
-
The study by the AAA Foundation for Traffic Safety found that medications such as amphetamines and cough medicines may cause dizziness, sleepiness, blurred vision and slow response time.
-
Since 2007, the supermarket chain has provided more than 100 million free prescription drugs to customers at its 1,200 pharmacies.
-
The state, which continues to wait for FDA approval, expects to import drugs to treat asthma, COPD, diabetes, hepatitis C, HIV and AIDS, and mental health conditions.